Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
You must be a Standard 1 Year member to access this content.
Milbank advised Viking Holdings Ltd on the offering, Latham & Watkins advised the underwriters and Ropes & Gray advised the selling shareholders. Viking Holdings Ltd (NYSE:...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised TransMedics Group Inc. on the deal. TransMedics Group Inc., a medical technology company transforming organ transplant therapy for patients with end-stage lung,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Sarepta Therapeutics on the deal. Sarepta Therapeutics, Inc. announced separate, privately negotiated exchange agreements with certain holders of its 1.50% Convertible Senior...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell and Shearman & Sterling advised TPG, while Ropes & Gray acted as counsel to the underwriters in the IPO. TPG, a leading...
You must be a Standard 1 Year member to access this content.
